References
- TokerMIErdemHErdoganHThe effects of topical ketorolac and indomethacin on measles conjunctivitis: randomized controlled trialAm J Ophthalmol2006141590290516527227
- AllegriPMurialdoUPeriSRandomized, double-blind, placebo-controlled clinical trial on the efficacy of 0.5% indomethacin eye drops in uveitic macular edemaInvest Ophthalmol Vis Sci20145531463147024519421
- WeberMKodjikianLKruseFEZagorskiZAllaireCMEfficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgeryActa Ophthalmol2013911e15e2122970738
- WaterburyLDSillimanDJolasTComparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodiumCurr Med Res Opin20062261133114016846546
- van HaeringenNJvan SorgeAACarballosa Coré-BodelierVMConstitutive cyclooxygenase-1 and induced cyclooxygenase-2 in isolated human iris inhibited by S(+) flurbiprofenJ Ocul Pharmacol Ther200016435336110977131
- DieboldYCalongeMApplications of nanoparticles in ophthalmologyProg Retin Eye Res201029659660920826225
- ChhonkerYSPrasadYDChandasanaHAmphotericin-B entrapped lecithin/chitosan nanoparticles for prolonged ocular applicationInt J Biol Macromol2015721451145825453292
- LeonardiABucoloCDragoFSalomoneSPignatelloRCationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbitInt J Pharm2015478118018625448580
- UrttiAChallenges and obstacles of ocular pharmacokinetics and drug deliveryAdv Drug Deliv Rev200658111131113517097758
- PatelACholkarKAgrahariVMitraAKOcular drug delivery systems: an overviewWorld J Pharmacol201322476425590022
- CholkarKPatelAVadlapudiADMitraAKNovel Nanomicellar formulation approaches for anterior and posterior segment ocular drug deliveryRecent Pat Nanomed201222829525400717
- FangueiroJFVeigaFSilvaAMSoutoEBOcular Drug Delivery – New Strategies for Targeting Anterior and Posterior Segments of the EyeCurr Pharm Des20162291135114626675225
- NagaiNNakazawaYItoYKanaiKOkamotoNShimomuraYA nanoparticle-based ophthalmic formulation of dexamethasone enhances corneal permeability of the drug and prolongs its corneal residence timeBiol Pharm Bull20174071055106228674248
- NagaiNYoshiokaCManoYA nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressureExp Eye Res201513211512325633346
- NagaiNItoYOkamotoNShimomuraYA nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeabilityToxicology2014319536224598350
- DeguchiSOtakeHNakazawaYHiramatsuNYamamotoNNagaiNOphthalmic formulation containing nilvadipine nanoparticles prevents retinal dysfunction in rats injected with streptozotocinInt J Mol Sci201718122720
- NagaiNOnoHHashinoMItoYOkamotoNShimomuraYImproved corneal toxicity and permeability of tranilast by the preparation of ophthalmic formulations containing its nanoparticlesJ Oleo Sci201463217718624420060
- MajumderPBaxaUWalshSTRSchneiderJPDesign of a multicompartment hydrogel that facilitates time-resolved delivery of combination therapy and Synergized killing of glioblastomaAngew Chem Int Ed201857461504015044
- ZhangXHuWLiJTaoLWeiYA comparative study of cellular uptake and cytotoxicity of multi-walled carbon nanotubes, graphene oxide, and nanodiamondToxicol Res2012116268
- QinLZhangFLuXPolymeric micelles for enhanced lymphatic drug delivery to treat metastatic tumorsJ Control Release2013171213314223863448
- GrattonSERoppPAPohlhausPDThe effect of particle design on cellular internalization pathwaysProc Natl Acad Sci U S A200810533116131161818697944
- ProulxSTLucianiPDieterichLCKaramanSLerouxJCDetmarMExpansion of the lymphatic vasculature in cancer and inflammation: new opportunities for in vivo imaging and drug deliveryJ Control Release2013172255055723665257
- YoumIBazzilJDOttoJWCarusoANMurowchickJBYouanBBInfluence of surface chemistry on cytotoxicity and cellular uptake of nanocapsules in breast cancer and phagocytic cellsAaps J201416355056724700270
- RappoportJZFocusing on clathrin-mediated endocytosisBiochem J2008412341542318498251
- WangJByrneJDNapierMEDesimoneJMMore effective nano-medicines through particle designSmall20117141919193121695781
- ZhangSLiJLykotrafitisGBaoGSureshSSize-dependent endocytosis of nanoparticlesAdv Mater200921441942419606281
- VercauterenDVandenbrouckeREJonesATThe use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfallsMol Ther201018356156920010917
- DausendJMusyanovychADassMUptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cellsMacromol Biosci20088121135114318698581
- RaghuHSharma-WaliaNVeettilMVSadagopanSChandranBKaposi’s sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cellsJ Virol200983104895491119279100
- QualmannBKesselsMMKellyRBMolecular links between endocytosis and the actin cytoskeletonJ Cell Biol20001505F111F116 Review10974009
- HeZLiuKManalotoECold atmospheric plasma induces ATP-dependent endocytosis of nanoparticles and synergistic U373MG cancer cell deathSci Rep201881529829593309
- Araki-SasakiKOhashiYSasabeTAn SV40-immortalized human corneal epithelial cell line and its characterizationInvest Ophthalmol Vis Sci19953636146217534282
- NagaiNInomataMItoYContribution of aldehyde dehydrogenase 3A1 to disulfiram penetration through monolayers consisting of cultured human corneal epithelial cellsBiol Pharm Bull20083171444144818591790
- MägerILangelKLehtoTEiríksdóttirELangelUThe role of endocytosis on the uptake kinetics of luciferin-conjugated cell-penetrating peptidesBiochim Biophys Acta18182012502511
- MalomouzhAIMukhitovARProskurinaSEVyskocilFNikolskyEEThe effect of dynasore, a blocker of dynamin-dependent endocytosis, on spontaneous quantal and non-quantal release of acetylcholine in murine neuromuscular junctionsDokl Biol Sci2014459133033325560208
- HufnagelHHakimPLimaAHollfelderFFluid phase endocytosis contributes to transfection of DNA by PEI-25Mol Ther20091781411141719532143
- LongfaKJinSYingleiZZhongguiHThe endocytosis and intracellular fate of nanomedicines: implication for rational designAsian J Pharm Sci20138110
- CalvoPAlonsoMJVila-JatoJLRobinsonJRImproved ocular bioavailability of indomethacin by novel ocular drug carriersJ Pharm Pharmacol19964811114711528961163
- PisellaPJFillacierKElenaPPDebbaschCBaudouinCComparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbitsOphthalmic Res20003213810657748
- NagaiNMuraoTOeKItoYOkamotoNShimomuraYAn in vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T)Yakugaku Zasshi2011131698599121628988
- MoriKYoshiokaNKondoYTakeuchiTYamashitaHCatalytically active, magnetically separable, and water-soluble FePt nanoparticles modified with cyclodextrin for aqueous hydrogenation reactionsGreen Chem200911913371342
- GaoHShiWFreundLBMechanics of receptor-mediated endocytosisProc Natl Acad Sci U S A2005102279469947415972807
- ZhangSGaoHBaoGPhysical principles of nanoparticle cellular endocytosisACS Nano2015998655867126256227
- ChithraniBDChanWCElucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapesNano Lett2007761542155017465586
- YangDLiuDQinMIntestinal mucin induces more endocytosis but less transcytosis of nanoparticles across enterocytes by triggering nanoclustering and strengthening the retrograde pathwayACS Appl Mater Interfaces20181014114431145629485849
- AderemAUnderhillDMMechanisms of phagocytosis in macrophagesAnnu Rev Immunol199917159362310358769